GlassScriptAzurion 7 M20 Gc
Payments companies reported to CMS as associated with Azurion 7 M20 Gc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Azurion 7 M20 Gc, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Azurion 7 M20 Gc
These are the largest totals companies reported as associated with Azurion 7 M20 Gc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hamad Farhat | Oak Lawn, IL | Neurological Surgery | $240.15 |
| Omar Choudhri | Philadelphia, PA | Neurological Surgery | $221.50 |
| Jean Bismuth | Houston, TX | Vascular Surgery | $146.72 |
| Paul Teirstein | La Jolla, CA | Interventional Cardiology | $126.10 |
| Randall Demartino | Rochester, MN | Vascular Surgery | $76.58 |
| Jonathan Nitz | Peoria, IL | Surgery | $51.70 |
| Raguveer Murthy | Jacksonville, FL | Interventional Cardiology | $38.58 |
| Abdulghani Saadi | Zephyrhills, FL | Interventional Cardiology | $29.61 |
| Charity Beck | Anderson, IN | Nurse Practitioner | $22.15 |
| Jarret Sanders | Fayetteville, AR | Diagnostic Radiology | $20.31 |
Prescribed Azurion 7 M20 Gc?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.